SCHEMBL24372494

SCHEMBL24372494

c1ccc(-c2nc(-c3cccc4ccccc34)nc(-c3cccc4cc(-n5c6ccccc6c6ccccc65)ccc34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.43
▸ MAPT P10636 5/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 4/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ ATM Q13315 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24372487 0.94 KDM4E (0.39) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL23332337 0.94 KDM4E (0.37) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL26007154 0.93 KDM4E (0.38) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL22596394 0.93 KDM4E (0.41) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL26007160 0.93 MAPT (0.38) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL23561329 0.93 KDM4E (0.36) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL26010247 0.93 KDM4E (0.42) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL21448347 0.92 KDM4E (0.41) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL26006966 0.92 KDM4E (0.37) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL21448889 0.92 KDM4E (0.42) KDM4EMAPTALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131083-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131083-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME TELO2, TERT, LIMS1 KDM4E 3373/4885MAPT 2033/4885ALDH1A1 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback